Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
2022 · Molecular Cancer · 262 citations
https://doi.org/10.1186/s12943-022-01650-5
Y
Yiting Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
281
Citations
3
h-index
2
i10-index
Yiting Xu is an academic researcher from Central South University. The author has contributed to research in topics: Immune cells in cancer & Cancer-related molecular mechanisms research & Extracellular vesicles in disease. The author has an h-index of 3, co-authored 9 publications.
ORCID: 0000-0002-9144-3215Papers by this author
worksEffects of mesenchymal stem cell exosomes on trabecular meshwork cells via the NRF2 pathway
2025 · Journal of Pharmacy and Pharmacology · 0 citations
https://doi.org/10.1093/jpp/rgaf101
Longitudinal body mass index exposure-based threshold to prevent mortality for populations with type 2 diabetes mellitus
2026 · Cell Reports Medicine · 0 citations
https://doi.org/10.1016/j.xcrm.2025.102566
Glutamine metabolism tunes myeloid responses to drive resolution of inflammation during skin repair
2026 · Cell Reports · 0 citations
https://doi.org/10.1016/j.celrep.2026.117001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat